参考文献

［1］FOGOROS RN.Impact of the implantable def i brillator on mortality：the axiom of overall implantable cardioverter-def i brillator survival.Am J Cardiol，1996，78（5A）：57-61.

［2］POWELL BD，ASIRVATHAM SJ，PERSCHBACHER DL，et al.Noise，artifact，and oversensing related inappropriate ICD shock evaluation：ALTITUDE noise study.Pacing Clin Electrophysiol，2012，35（7）：863-869.

［3］DESAI H，ARONOW WS，AHN C，et al.Risk factors for appropriate cardioverter-def i brillator shocks，inappropriate cardioverter-def i brillator shocks，and time to mortality in 549 patients with heart failure.Am J Cardiol，2010，105（9）：1336-1338.

［4］MORGAN JM，STERNS LD，HANSON JL，et al.A trial design for evaluation of empiric programming of implantable cardioverter def i brillators to improve patient management.Curr Control Trials Cardiovasc Med，2004，5（1）：12.

［5］POWELL BD，SAXON LA，BOEHMER JP，et al.Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked.The ALTITUDE survival by rhythm study.J Am Coll Cardiol，2013，62（18）：1674-1679.

［6］GOLDBERGER JJ，HORVATH G，DONOVAN D，et al.Detection of ventricular fibrillation by transvenous def i brillating leads：integrated versus dedicated bipolar sensing.J Cardiovasc Electrophysiol，1998，9（7）：677-688.

［7］PATTON KK，HELLKAMP AS，LEE KL，et al.Unexpected deviation in circadian variation of ventricular arrhythmias：the SCD-HeFT（Sudden Cardiac Death in Heart Failure Trial）.J Am Coll Cardiol，2014，63（24）：2702-2708.

［8］SAXON LA，BRISTOW MR，BOEHMER J，et al.Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy，Pacing，and Def i brillation in Heart Failure（COMPANION）Trial.Circulation，2006，114（25）：2766-2772.

［9］KATRITSIS DG，SIONTIS KC，BIGGER JT，et al.Effect of left ventricular ejection fraction and QRS duration on the survival benefit of implantable cardioverter-defibrillators：meta-analysis of primary prevention trials.Heart Rhythm，2013，10（2）：200-206.

［10］SAXON LA，HAYES DL，GILLIAM FR，et al.Long-term outcome after ICD and CRT implantation and inf l uence of remote device follow-up：the ALTITUDE survival study.Circulation，2010，122（23）：2359-2367.

［11］HALDAR SK，STEED B，WATKINS S，et al.When ventricular safety stand by does not work.J Cardiovasc Electrophysiol，2017，28（5）：574-575.

［12］AOUKAR PS，POOLE JE，JOHNSON GW，et al.No benef i t of a dual coil over a single coil ICD lead：evidence from the sudden cardiac death in heart failure trial.Heart Rhythm，2013，10（7）：970-976.

［13］WILKOFF BL，WILLIAMSON BD，STERN RS，et al.Strategic programming of detection and therapy parameters in implantable cardioverter-def i brillators reduces shocks in primary prevention patients：results from the PREPARE（Primary Prevention Parameters Evaluation）study.J Am Coll Cardiol，2008，52（7）：541-550.

［14］TAN VH，WILTON SB，KURIACHAN V，et al.Impact of programming strategies aimed at reducing nonessential implantable cardioverter def i brillator therapies on mortality：a systematic review and metaanalysis.Circ Arrhythm Electrophysiol，2014，7（1）：164-170.

［15］GASPARINI M，LUNATI MG，PROCLEMER A，et al.Long Detection programming in singlechamber def i brillators reduces unnecessary therapies and mortality：the ADVANCE Ⅲ trial.JACC Clin Electrophysiol，2017，3（11）：1275-1282.